A constitutively active pituitary adenylate cyclase activating polypeptide(PACAP) type I receptor shows enhanced photoaffinity labeling of its highly glycosylated form
Yj. Cao et G. Gimpl, A constitutively active pituitary adenylate cyclase activating polypeptide(PACAP) type I receptor shows enhanced photoaffinity labeling of its highly glycosylated form, BBA-PROT ST, 1548(1), 2001, pp. 139-151
Citations number
43
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY
In the present study, we have analyzed a previously identified constitutive
ly active pituitary adenylate cyclase activating polypeptide (PACAP) type I
(PAC1) receptor with a deletion of the single amino acid residue Glu261 (Y
.-J. Cao. G. Gimpl. F. Fahrenholz, A mutation of second intracellular loop
of pituitary adenylate cyclase activating polypeptide type I receptor confe
rs constitutive receptor activation. FEES Lett. 469 11000)). This glutamic
acid residue is highly conserved within the second intracellular loop of cl
ass IT G protein-coupled receptors and may thus be of importance for many m
embers of this receptor class. To explore the molecular characteristics of
this mutant receptor, we performed photoaffinity labeling using previously
defined photoreactive PACAP analogues. In COS cells, the PAC1 receptor was
expressed in two differently glycosylated forms: a M-r 75 000 and a M-r 55
000 form. According to partial deglycosylation, at least three carbohydrate
chains may exist in the rat PAC1 receptor expressed in COS cells. The cons
titutively active PAC1 receptor was expressed at the surface of COS-7 cells
at the same density as the wild-type receptor. With respect to the differe
nt photoreactive PACAP analogues, the labeling specificity was the same for
the wild-type versus mutant receptor. I-125-[Lys(15)(pBz(2))]-PACAP-27 and
I-125-[Bpa(22)]-PACAP-27 were efficiently incorporated into each of the re
ceptors, whereas I-125-[Bpa(6)]-PACAP-27 labeled each of the receptors only
to a negligible extent. This suggests that both receptors have the same or
at least a very similar hormone binding site which is in close contact to
Tyr(22) and Lys(15) located in the carboxy-terminal a-helical region of the
PACAP-27 molecule. However, in comparison with the wild-type PAC1 receptor
. the constitutively active receptor showed a markedly (approx. 6-8-fold) e
nhanced photoaffinity labeling efficiency in particular of the high glycosy
lated form. The enzymatically deglycosylated rat PAC1 receptor was efficien
tly labeled by photoreactive PACAP analogues. In contrast, nonglycosylated
PAC1 receptors produced by tunicamycin treatment of the transfected COS-7 c
ells showed a 30-fold lower affinity for PACAP-27 and were capable of signa
l transduction with 30-50-fold lower potency as compared with the glycosyla
ted PAC 1 receptors. (C) 2001 Published by Elsevier Science B.V.